Journals / Türk Toraks Dergisi / 2010 / Cilt: 11 - Sayı: 2

The diagnostic value of pleural fluid neopterin level in tuberculous pleurisy

Tüberküloz plörezide plevral sıvı neopterin düzeyinin tanısal değeri

Pages
62–65
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: According to this study's results, pleural neopterin has no diagnostic value in TP. (Tur Toraks Der 2010; 11: 62-5)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Neopterin is derived from guanosine-triphosphate, produced by stimulated macrophages under the influence of gamma interferon (IFN-γ) of CD4 T lymphocyte origin.
📊
Key Findings & Data:Material and Method: 70 patients with pleural effusion (19 transudative pleural effusion, 19 malignant pleural effusion (MPE), 18 parapneumonic effusion (PPE) and 14 TP) were enrolled in the study.
💡
Conclusion & Impact:Conclusion: According to this study's results, pleural neopterin has no diagnostic value in TP. (Tur Toraks Der 2010; 11: 62-5)
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Neopterin is derived from guanosine-triphosphate, produced by stimulated macrophages under the influence of gamma interferon (IFN-γ) of CD4 T lymphocyte origin. It has been reported that the pleural neopterin level is higher in tuberculous pleurisy (TP) than nontuberculous pleural effusions. In the presented study, the diagnostic value of pleural neopterin in tuberculous pleurisy was investigated. Material and Method: 70 patients with pleural effusion (19 transudative pleural effusion, 19 malignant pleural effusion (MPE), 18 parapneumonic effusion (PPE) and 14 TP) were enrolled in the study. Results: The mean neopterin level was 32.73±26.20 nmol/L in transudative effusion and 19.34±15.32 nmol/L in exudative effusion and there was no significant difference. The mean neopterin level was 19.84±15.94 nmol/L in TP, 26.8±20.16 nmol/L in PPE and 12.52±4.24 nmol/L in MPE. While the pleural neopterin level was significantly higher in transudative effusion and PPE than MPE, there was no significant difference between TP and other groups. Conclusion: According to this study's results, pleural neopterin has no diagnostic value in TP. (Tur Toraks Der 2010; 11: 62-5)

Özet

Amaç: Neopterin, CD4 T lenfosit kaynaklı interferon gama (IFN-γ) stimülasyonuna bağlı olarak makrofajlarda sentezlenen bir guanozin trifosfat metabolitidir ve plevral sıvı neopterin düzeylerinin tüberküloz plörezi (TP)'de tüberküloz dışı nedene bağlı plevral sıvılara göre daha yüksek saptandığı bildirilmektedir. Bu çalışmada TP'de neopterinin tanısal değeri araştırılmıştır. Gereç ve Yöntem: Çalışmaya 19 transüda, 19 malign plevral efüzyon (MPE), 18 parapnömonik efüzyon (PPE) ve 14 TP olmak üzere toplam 70 olgu alındı. Bulgular: Transüdatif sıvılarda ortalama neopterin düzeyi 32.73±26.20 nmol/L, eksüdatif sıvılarda ise 19.34±15.32 nmol/L olarak saptandı ve iki grup arasında fark yoktu. Ortalama neopterin düzeyi, TP grubunda 19.84±15.94 nmol/L, PPE grubunda 26.8±20.16 nmol/L ve MPE grubunda 12.52±4.24 nmol/L olarak bulundu. Transüda ve PPE grubunda neopterin düzeyi MPE grubuna göre anlamlı olarak daha yüksekken, TP ile diğer gruplar arasında anlamlı fark saptanmadı. Sonuç: Bu çalışmanın sonuçlarına göre, TP'de plevral sıvı neopterin ölçümünün tanısal değeri bulunmamaktadır.

🔖

Cite This Article

EROL, S., ÇİLEDAĞ, A., KAYA, A., CESUR, S., FİDAN, Y., KINIKLI, S., NUMANOĞLU, N. (2010). The diagnostic value of pleural fluid neopterin level in tuberculous pleurisy. Türk Toraks Dergisi, Cilt: 11 - Sayı: 2, 62–65. https://ajindex.com/articles/329544

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. World Health Organization. Gobal tuberculosis control 2009: epidemiology, strategy, financing. Geneva, Switzerland: World Health Organization; 2008. Publication no. WHO/HTM/TB/2009. 411 2) Valdes L, Pose A, San Jose E, et al. Tuberculous pleural effusions. Eur J Intern Med 2003;14:77-88. 3) Liam CK, Lim KH, Wong CM. Causes of pleural exudates in a region with a high incidence of tuberculosis. Respirology 2000;5:33-8. 4) Valdes L, Alvarez D,Valle JM, et al. The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 1996;109:158-62. 5) Trajman A, Pai M, Dheda K, et al. Novel tests for diagnosing tuberculous pleural effusion: what works and what dose not? Eur Respir J 2008;31:1098-106. 6) Baganha MF, ota-Pinto A, Pego MA, et al. Neopterin in tuberculous and neoplastic pleural fluids. Lung 1992;170:155-61. 7) Tozkoparan E, Deniz O, Cakir E, et al. The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy. Int J Tuberc Lung Dis 2005;9:1040-5. 8) San Jose E, Alvarez D, Valle JM, et al. Comparative evaluation of neopterin, lysozyme, and adenosinedeaminase in pleural fluid as markers of tuberculous pleurisy. Chest 1996;110:50-1. 9) Cok G, Parildar Z, Basol G, et al. Pleural fluid neopterin levels in tuberculous pleurisy. Clinical Biochemistry 2007;40:876-80. 10) Light RW, McGregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic seperation of transudates and exudates. Ann Intern Med 1972;77:507 13. 11) Güler M, Hüddam D, Ünsal E, ve ark. Akciğer tüberkülozlu hastalarda aktivasyon ve tedaviye yanıtın değerlendirilmesinde serum neopterin düzeyinin yeri. Tüberküloz ve Toraks Dergisi 2006;54:330-5. 12) Turgut T, Akbulut H, Deveci F, et al. Serum Interleukin-2 and Neopterin Levels as Useful Markers for Treatment of Active Pulmonary Tuberculosis. Tohoku J Exp Med 2006;209:321-8. 13) Chiang CS, Chiang CD, Lin JW, et al. Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions. Respiration 1994;61:150-4. 14) Berdowska A, Zwirska-Korczala K. Neopterin measurements in clinical diagnosis. Journal of Clinical Pharmacy and Therapeutics 2001;26:319-29. 15) Ray KK, Morrow DA, Sabatine MS. Long-term prognostic value of neopterin a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 2007;115:3071-8. 16) Jortani SA, Prabhu SD,Valdes R. Strategies for developing biomarkers of heart failure. Clinical Chemistry 2004;50:265-7